• Kari A. O. TikkinenEmail author
  • Theodore M. JohnsonII
  • Jeffrey P. Weiss


The definition of nocturia is a critical factor in evaluating its epidemiology. The International Continence Society (ICS) classifies nocturia as one of the urinary storage symptoms and defines nocturia as “the complaint that the individual has to wake at night one or more times to void…each void is preceded and followed by sleep.” Several other definitions with subtle differences have also been published. Nocturia is extremely common among older adults, with incidence and prevalence increasing with advancing age. The cause is generally considered multifactorial, but a number of common clinical conditions seen in older adults increase risk. This chapter reviews the epidemiology, evaluation and treatment for nocturia in geriatric patients.


Benign Prostatic Hyperplasia Stress Urinary Incontinence Lower Urinary Tract Symptom Bladder Capacity Menopausal Hormone Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Weiss JP, Blaivas JG. Nocturia. J Urol. 2000;163(1):5–12.PubMedGoogle Scholar
  2. 2.
    van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):179–83.PubMedGoogle Scholar
  3. 3.
    Tikkinen KAO, Johnson TM, Cartwright R. Epidemiology of nocturia: evaluation of prevalence, incidence, impact and risk factors. In: Weiss JP, Blaivas JG, van Kerrebroeck PEV, Wein AJ, editors. Nocturia: causes, consequences and clinical approaches. New York, NY: Springer; 2011. p. 77–108.Google Scholar
  4. 4.
    Hunskaar S. Epidemiology of nocturia. BJU Int. 2005;96 Suppl 1:4–7.PubMedGoogle Scholar
  5. 5.
    Weber AM, Abrams P, Brubaker L, Cundiff G, Davis G, Dmochowski RR, et al. The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(3):178–86.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4–20.PubMedGoogle Scholar
  7. 7.
    Weiss JP, Wein AJ, van Kerrebroeck P, Dmochowski R, Fitzgerald MP, Tikkinen KAO, et al. Nocturia: new directions ICI-RS Think Tank 2010. Neurourol Urodyn. 2011;30(5):723–8.Google Scholar
  8. 8.
    Tikkinen KA, Tammela TL, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol. 2006;175(2):596–600.PubMedGoogle Scholar
  9. 9.
    Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol. 2010;184(2):440–6.PubMedGoogle Scholar
  10. 10.
    Tikkinen KA, Johnson TM, Tammela TL, Sintonen H, Haukka J, Huhtala H, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol. 2010;7(3):488–96.Google Scholar
  11. 11.
    Tikkinen KAO. Epidemiology of Nocturia—Results from the FINNO Study [dissertation]. Tampere, Finland: Tampere University Press; 2010. Available at
  12. 12.
    Britton JP, Dowell AC, Whelan P. Prevalence of urinary symptoms in men aged over 60. Br J Urol. 1990;66(2):175–6.PubMedGoogle Scholar
  13. 13.
    Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991;338(8765):469–71.PubMedGoogle Scholar
  14. 14.
    Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993;150(1):85–9.PubMedGoogle Scholar
  15. 15.
    Sagnier PP, MacFarlane G, Richard F, Botto H, Teillac P, Boyle P. Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J Urol. 1994;151(5):1266–70.PubMedGoogle Scholar
  16. 16.
    Homma Y, Imajo C, Takahashi S, Kawabe K, Aso Y. Urinary symptoms and urodynamics in a normal elderly population. Scand J Urol Nephrol Suppl. 1994;157:27–30.PubMedGoogle Scholar
  17. 17.
    Malmsten UG, Milsom I, Molander U, Norlen LJ. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99 years. J Urol. 1997;158(5):1733–7.PubMedGoogle Scholar
  18. 18.
    Sommer P, Nielsen KK, Bauer T, Kristensen ES, Hermann GG, Steven K, et al. Voiding patterns in men evaluated by a questionnaire survey. Br J Urol. 1990;65(2):155–60.PubMedGoogle Scholar
  19. 19.
    Brieger GM, Yip SK, Hin LY, Chung TK. The prevalence of urinary dysfunction in Hong Kong Chinese women. Obstet Gynecol. 1996;88(6):1041–4.PubMedGoogle Scholar
  20. 20.
    Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20-59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand. 1997;76(1):74–80.PubMedGoogle Scholar
  21. 21.
    Pinnock C, Marshall VR. Troublesome lower urinary tract symptoms in the community: a prevalence study. Med J Aust. 1997;167(2):72–5.PubMedGoogle Scholar
  22. 22.
    Schatzl G, Temml C, Schmidbauer J, Dolezal B, Haidinger G, Madersbacher S. Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project. Urology. 2000;56(1):71–5.PubMedGoogle Scholar
  23. 23.
    van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int. 2002;90(7):644–8.PubMedGoogle Scholar
  24. 24.
    Rembratt A, Norgaard JP, Andersson KE. Nocturia and associated morbidity in a community-dwelling elderly population. BJU Int. 2003;92(7):726–30.PubMedGoogle Scholar
  25. 25.
    Coyne KS, Zhou Z, Bhattacharyya SK, Thompson CL, Dhawan R, Versi E. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int. 2003;92(9):948–54.PubMedGoogle Scholar
  26. 26.
    Yoshimura K, Terada N, Matsui Y, Terai A, Kinukawa N, Arai Y. Prevalence of and risk factors for nocturia: analysis of a health screening program. Int J Urol. 2004;11(5):282–7.PubMedGoogle Scholar
  27. 27.
    Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC Study. Eur Urol. 2006;50(6):1306–15.PubMedGoogle Scholar
  28. 28.
    Herschorn S, Gajewski J, Schulz J, Corcos J. A population-based study of urinary symptoms and incontinence: the Canadian Urinary Bladder Survey. BJU Int. 2008;101(1):52–8.PubMedGoogle Scholar
  29. 29.
    Choo MS, Ku JH, Park CH, Lee YS, Lee KS, Lee JG, et al. Prevalence of nocturia in a Korean population aged 40 to 89 years. Neurourol Urodyn. 2008;27(1):60–4.PubMedGoogle Scholar
  30. 30.
    Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol. 2011;185(2):571–7.PubMedGoogle Scholar
  31. 31.
    Zhang X, Zhang J, Chen J, Zhang C, Li Q, Xu T, et al. Prevalence and risk factors of nocturia and nocturia-related quality of life in the Chinese population. Urol Int. 2011;86(2):173–8.PubMedGoogle Scholar
  32. 32.
    McGrother CW, Donaldson MM, Shaw C, Matthews RJ, Hayward TA, Dallosso HM, et al. Storage symptoms of the bladder: prevalence, incidence and need for services in the UK. BJU Int. 2004;93(6):763–9.PubMedGoogle Scholar
  33. 33.
    Muscatello DJ, Rissel C, Szonyi G. Urinary symptoms and incontinence in an urban community: prevalence and associated factors in older men and women. Intern Med J. 2001;31(3):151–60.PubMedGoogle Scholar
  34. 34.
    Parsons M, Tissot W, Cardozo L, Diokno A, Amundsen CL, Coats AC, et al. Normative bladder diary measurements: night versus day. Neurourol Urodyn. 2007;26(4):465–73.PubMedGoogle Scholar
  35. 35.
    Blanker MH, Bohnen AM, Groeneveld FP, Bernsen RM, Prins A, Ruud Bosch JL. Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men. J Urol. 2000;164(4):1201–5.PubMedGoogle Scholar
  36. 36.
    Hunskaar S. Fluctuations in lower urinary tract symptoms in women. Reassurance and watchful waiting can prevent overtreatment BMJ. 2000;320(7247):1418–9.Google Scholar
  37. 37.
    Moller LA, Lose G, Jorgensen T. Incidence and remission rates of lower urinary tract symptoms at one year in women aged 40-60: longitudinal study. BMJ. 2000;320(7247):1429–32.PubMedCentralPubMedGoogle Scholar
  38. 38.
    Johnson TM, Sattin RW, Parmelee P, Fultz NH, Ouslander JG. Evaluating potentially modifiable risk factors for prevalent and incident nocturia in older adults. J Am Geriatr Soc. 2005;53(6):1011–6.PubMedGoogle Scholar
  39. 39.
    Yoshimura K, Kamoto T, Tsukamoto T, Oshiro K, Kinukawa N, Ogawa O. Seasonal alterations in nocturia and other storage symptoms in three Japanese communities. Urology. 2007;69(5):864–70.PubMedGoogle Scholar
  40. 40.
    van Doorn B, Blanker MH, Kok ET, Westers P, Bosch JL. Once nocturia, always nocturia? Natural history of nocturia in older men based on frequency-volume charts: the Krimpen study. J Urol. 2011;186(5):1956–61.PubMedGoogle Scholar
  41. 41.
    Herzog AR, Fultz NH. Prevalence and incidence of urinary incontinence in community-dwelling populations. J Am Geriatr Soc. 1990;38(3):273–81.PubMedGoogle Scholar
  42. 42.
    Hakkinen JT, Hakama M, Shiri R, Auvinen A, Tammela TL, Koskimaki J. Incidence of nocturia in 50 to 80-year-old Finnish men. J Urol. 2006;176(6 Pt 1):2541–5. discussion 2545.PubMedGoogle Scholar
  43. 43.
    Malmsten UG, Molander U, Peeker R, Irwin DE, Milsom I. Urinary incontinence, overactive bladder, and other lower urinary tract symptoms: a longitudinal population-based survey in men aged 45-103 years. Eur Urol. 2010;58(1):149–56.PubMedGoogle Scholar
  44. 44.
    Viktrup L. The risk of lower urinary tract symptoms five years after the first delivery. Neurourol Urodyn. 2002;21(1):2–29.PubMedGoogle Scholar
  45. 45.
    Viktrup L, Lose G. Incidence and remission of lower urinary tract symptoms during 12 years after the first delivery: a cohort study. J Urol. 2008;180(3):992–7.PubMedGoogle Scholar
  46. 46.
    Paunio T, Korhonen T, Hublin C, Partinen M, Kivimaki M, Koskenvuo M, et al. Longitudinal study on poor sleep and life dissatisfaction in a nationwide cohort of twins. Am J Epidemiol. 2009;169(2):206–13.PubMedGoogle Scholar
  47. 47.
    King CR, Knutson KL, Rathouz PJ, Sidney S, Liu K, Lauderdale DS. Short sleep duration and incident coronary artery calcification. JAMA. 2008;300(24):2859–66.PubMedCentralPubMedGoogle Scholar
  48. 48.
    Hublin C, Partinen M, Koskenvuo M, Kaprio J. Sleep and mortality: a population-based 22-year follow-up study. Sleep. 2007;30(10):1245–53.PubMedCentralPubMedGoogle Scholar
  49. 49.
    Asplund R, Aberg H. Health of the elderly with regard to sleep and nocturnal micturition. Scand J Prim Health Care. 1992;10(2):98–104.PubMedGoogle Scholar
  50. 50.
    Abraham L, Hareendran A, Mills IW, Martin ML, Abrams P, Drake MJ, et al. Development and validation of a quality-of-life measure for men with nocturia. Urology. 2004;63(3):481–6.PubMedGoogle Scholar
  51. 51.
    Mock LL, Parmelee PA, Kutner N, Scott J, Johnson TM. Content validation of symptom-specific nocturia quality-of-life instrument developed in men: issues expressed by women, as well as men. Urology. 2008;72(4):736–42.PubMedGoogle Scholar
  52. 52.
    Booth JM, Lawrence M, O’Neill K, McMillan L. Exploring older peoples’ experiences of nocturia: a poorly recognised urinary condition that limits participation. Disabil Rehabil. 2010;32(9):765–74.PubMedGoogle Scholar
  53. 53.
    Vaughan CP, Eisenstein R, Bliwise DL, Endeshaw YK, Nagamia ZJ, Wolf RA, et al. Self-rated sleep characteristics and bother from nocturia. Int J Clin Pract. 2012;66(4):369–73.PubMedGoogle Scholar
  54. 54.
    Endeshaw Y. Correlates of self-reported nocturia among community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2009;64(1):142–8.PubMedGoogle Scholar
  55. 55.
    Middelkoop HA, den Smilde-van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Subjective sleep characteristics of 1,485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol A Biol Sci Med Sci. 1996;51(3):M108–15.PubMedGoogle Scholar
  56. 56.
    Bing MH, Moller LA, Jennum P, Mortensen S, Skovgaard LT, Lose G. Prevalence and bother of nocturia, and causes of sleep interruption in a Danish population of men and women aged 60-80 years. BJU Int. 2006;98(3):599–604.PubMedGoogle Scholar
  57. 57.
    Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2009;10(5):540–8.PubMedCentralPubMedGoogle Scholar
  58. 58.
    Pressman MR, Figueroa WG, Kendrick-Mohamed J, Greenspon LW, Peterson DD. Nocturia. A rarely recognized symptom of sleep apnea and other occult sleep disorders Arch Intern Med. 1996;156(5):545–50.Google Scholar
  59. 59.
    Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol. 1995;153(3 Pt 1):669–73.PubMedGoogle Scholar
  60. 60.
    Fiske J, Scarpero HM, Xue X, Nitti VW. Degree of bother caused by nocturia in women. Neurourol Urodyn. 2004;23(2):130–3.PubMedGoogle Scholar
  61. 61.
    Liew LC, Tiong HY, Wong ML, Png DC, Tan JK. A population study of nocturia in Singapore. BJU Int. 2006;97(1):109–12.PubMedGoogle Scholar
  62. 62.
    Yu HJ, Chen FY, Huang PC, Chen TH, Chie WC, Liu CY. Impact of nocturia on symptom-specific quality of life among community-dwelling adults aged 40 years and older. Urology. 2006;67(4):713–8.PubMedGoogle Scholar
  63. 63.
    Lowenstein L, Brubaker L, Kenton K, Kramer H, Shott S, FitzGerald MP. Prevalence and impact of nocturia in a urogynecologic population. Int Urogynecol J Pelvic Floor Dysfunct. 2007;18(9):1049–52.PubMedGoogle Scholar
  64. 64.
    Kupelian V, Wei JT, O’Leary MP, Norgaard JP, Rosen RC, McKinlay JB. Nocturia and quality of life: results from the Boston Area Community Health Survey. Eur Urol. 2012;61(1):78–84.PubMedCentralPubMedGoogle Scholar
  65. 65.
    Jarvinen TL, Sievanen H, Khan KM, Heinonen A, Kannus P. Shifting the focus in fracture prevention from osteoporosis to falls. BMJ. 2008;336(7636):124–6.PubMedCentralPubMedGoogle Scholar
  66. 66.
    Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc. 1992;40(12):1217–20.PubMedGoogle Scholar
  67. 67.
    Brown JS, Vittinghoff E, Wyman JF, Stone KL, Nevitt MC, Ensrud KE, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000;48(7):721–5.PubMedGoogle Scholar
  68. 68.
    Temml C, Ponholzer A, Gutjahr G, Berger I, Marszalek M, Madersbacher S. Nocturia is an age-independent risk factor for hip-fractures in men. Neurourol Urodyn. 2009;28(8):949–52.PubMedGoogle Scholar
  69. 69.
    Asplund R. Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch Gerontol Geriatr. 2006;43(3):319–26.PubMedGoogle Scholar
  70. 70.
    Parsons JK, Mougey J, Lambert L, Wilt TJ, Fink HA, Garzotto M, et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 2009;104(1):63–8.PubMedCentralPubMedGoogle Scholar
  71. 71.
    Vaughan CP, Brown CJ, Goode PS, Burgio KL, Allman RM, Johnson TM. The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract. 2010;64(5):577–83.PubMedCentralPubMedGoogle Scholar
  72. 72.
    Nakagawa H, Niu K, Hozawa A, Ikeda Y, Kaiho Y, Ohmori-Matsuda K, et al. Impact of nocturia on bone fracture and mortality in older individuals: a Japanese longitudinal cohort study. J Urol. 2010;184(4):1413–8.PubMedGoogle Scholar
  73. 73.
    Asplund R. Mortality in the elderly in relation to nocturnal micturition. BJU Int. 1999;84(3):297–301.PubMedGoogle Scholar
  74. 74.
    Bursztyn M, Jacob J, Stessman J. Usefulness of nocturia as a mortality risk factor for coronary heart disease among persons born in 1920 or 1921. Am J Cardiol. 2006;98(10):1311–5.PubMedGoogle Scholar
  75. 75.
    Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users’ guides to the medical literature IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA. 1995;274(22):1800–4.PubMedGoogle Scholar
  76. 76.
    Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ. 2008;336(7653):1106–10.PubMedCentralPubMedGoogle Scholar
  77. 77.
    Yu HJ, Chen TH, Chie WC, Liu CY, Tung TH, Huang SW. Prevalence and associated factors of nocturia among adult residents of the Matsu area of Taiwan. J Formos Med Assoc. 2005;104(6):444–7.PubMedGoogle Scholar
  78. 78.
    Tikkinen KA, Auvinen A, Johnson TM, Weiss JP, Keranen T, Tiitinen A, et al. A systematic evaluation of factors associated with nocturia–the population-based FINNO study. Am J Epidemiol. 2009;170(3):361–8.PubMedCentralPubMedGoogle Scholar
  79. 79.
    Homma Y, Yamaguchi T, Kondo Y, Horie S, Takahashi S, Kitamura T. Significance of nocturia in the International Prostate Symptom Score for benign prostatic hyperplasia. J Urol. 2002;167(1):172–6.PubMedGoogle Scholar
  80. 80.
    Yoshimura K, Ohara H, Ichioka K, Terada N, Matsui Y, Terai A, et al. Nocturia and benign prostatic hyperplasia. Urology. 2003;61(4):786–90.PubMedGoogle Scholar
  81. 81.
    Johnson TM, Burrows PK, Kusek JW, Nyberg LM, Tenover JL, Lepor H, et al. The effect of doxazosin, finasteride and combination therapy on nocturia in men with benign prostatic hyperplasia. J Urol. 2007;78(5):2045. discussion 2050-1.Google Scholar
  82. 82.
    Abrams PH, Farrar DJ, Turner-Warwick RT, Whiteside CG, Feneley RC. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol. 1979;121(5):640–2.PubMedGoogle Scholar
  83. 83.
    Bruskewitz RC, Larsen EH, Madsen PO, Dorflinger T. 3-year follow-up of urinary symptoms after transurethral resection of the prostate. J Urol. 1986;136(3):613–5.PubMedGoogle Scholar
  84. 84.
    Asplund R, Henriksson S, Johansson S, Isacsson G. Nocturia and depression. BJU Int. 2004;93(9):1253–6.PubMedGoogle Scholar
  85. 85.
    Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord. 2001;66(2–3):159–64.PubMedGoogle Scholar
  86. 86.
    Asplund R, Johansson S, Henriksson S, Isacsson G. Nocturia, depression and antidepressant medication. BJU Int. 2005;95(6):820–3.PubMedGoogle Scholar
  87. 87.
    McKeigue PM, Reynard JM. Relation of nocturnal polyuria of the elderly to essential hypertension. Lancet. 2000;355(9202):486–8.PubMedGoogle Scholar
  88. 88.
    Burgio KL, Johnson TM, Goode PS, Markland AD, Richter HE, Roth DL, et al. Prevalence and correlates of nocturia in community-dwelling older adults. J Am Geriatr Soc. 2010;58(5):861–6.PubMedCentralPubMedGoogle Scholar
  89. 89.
    Hall SA, Chiu GR, Kaufman DW, Wittert GA, Link CL, McKinlay JB (2011) Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. BJU Int. 2012;109(11):1676–84.Google Scholar
  90. 90.
    Bulpitt CJ, Connor M, Schulte M, Fletcher AE. Bisoprolol and nifedipine retard in elderly hypertensive patients: effect on quality of life. J Hum Hypertens. 2000;14(3):205–12.PubMedGoogle Scholar
  91. 91.
    Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol. 1998;81(2):215–8.PubMedGoogle Scholar
  92. 92.
    Gourova LW, van de Beek C, Spigt MG, Nieman FH, van Kerrebroeck PE. Predictive factors for nocturia in elderly men: a cross-sectional study in 21 general practices. BJU Int. 2006;97(3):528–32.PubMedGoogle Scholar
  93. 93.
    Fitzgerald MP, Litman HJ, Link CL, McKinlay JB. BACH Survey Investigators. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol. 2007;177(4):1385–9.PubMedGoogle Scholar
  94. 94.
    Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313):1221–31.PubMedGoogle Scholar
  95. 95.
    DasGupta R, Fowler CJ. Bladder, bowel and sexual dysfunction in multiple sclerosis: management strategies. Drugs. 2003;63(2):153–66.PubMedGoogle Scholar
  96. 96.
    Asplund R. Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. BJU Int. 2002;90(6):533–6.PubMedGoogle Scholar
  97. 97.
    Young A, Home M, Churchward T, Freezer N, Holmes P, Ho M. Comparison of sleep disturbance in mild versus severe Parkinson’s disease. Sleep. 2002;25(5):573–7.PubMedGoogle Scholar
  98. 98.
    Hornyak M, Kopasz M, Berger M, Riemann D, Voderholzer U. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry. 2005;66(9):1139–45.PubMedGoogle Scholar
  99. 99.
    Pearson VE, Gamaldo CE, Allen RP, Lesage S, Hening WA, Earley CJ. Medication use in patients with restless legs syndrome compared with a control population. Eur J Neurol. 2008;15(1):16–21.PubMedGoogle Scholar
  100. 100.
    Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women – a population-based study in Finland. Am J Obstet Gynecol. 2008;199(2):153.e1-12.PubMedGoogle Scholar
  101. 101.
    Alling Moller L, Lose G, Jorgensen T. Risk factors for lower urinary tract symptoms in women 40 to 60 years of age. Obstet Gynecol. 2000;96(3):446–51.PubMedGoogle Scholar
  102. 102.
    Asplund R, Aberg HE. Development of nocturia in relation to health, age and the menopause. Maturitas. 2005;51(4):358–62.PubMedGoogle Scholar
  103. 103.
    Rekers H, Drogendijk AC, Valkenburg HA, Riphagen F. The menopause, urinary incontinence and other symptoms of the genitourinary tract. Maturitas. 1992;15(2):101–11.PubMedGoogle Scholar
  104. 104.
    Lin TL, Ng SC, Chen YC, Hu SW, Chen GD. What affects the occurrence of nocturia more: menopause or age? Maturitas. 2005;50(2):71–7.PubMedGoogle Scholar
  105. 105.
    Moline ML, Broch L, Zak R, Gross V. Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev. 2003;7(2):155–77.PubMedGoogle Scholar
  106. 106.
    Cardozo L, Rekers H, Tapp A, Barnick C, Shepherd A, Schussler B, et al. Oestriol in the treatment of postmenopausal urgency: a multicentre study. Maturitas. 1993;18(1):47–53.PubMedGoogle Scholar
  107. 107.
    Lose G, Englev E. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG. 2000;107(8):1029–34.PubMedGoogle Scholar
  108. 108.
    Liapis A, Bakas P, Georgantopoulou C, Creatsas G. The use of oestradiol therapy in postmenopausal women after TVT-O anti-incontinence surgery. Maturitas. 2010;66(1):101–6.PubMedGoogle Scholar
  109. 109.
    Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.PubMedGoogle Scholar
  110. 110.
    Blanker MH, Bernsen RM, Ruud Bosch JL, Thomas S, Groeneveld FP, Prins A, et al. Normal values and determinants of circadian urine production in older men: a population based study. J Urol. 2002;168(4 Pt 1):1453–7.PubMedGoogle Scholar
  111. 111.
    Torimoto K, Hirayama A, Samma S, Yoshida K, Fujimoto K, Hirao Y. The relationship between nocturnal polyuria and the distribution of body fluid: assessment by bioelectric impedance analysis. J Urol. 2009;181(1):219,24. discussion 224.PubMedGoogle Scholar
  112. 112.
    Sugaya K, Nishijima S, Owan T, Oda M, Miyazato M, Ogawa Y. Effects of walking exercise on nocturia in the elderly. Biomed Res. 2007;28(2):101–5.PubMedGoogle Scholar
  113. 113.
    Asplund R. The nocturnal polyuria syndrome (NPS). Gen Pharmacol. 1995;26(6):1203–9.PubMedGoogle Scholar
  114. 114.
    Miller M. Nocturnal polyuria in older people: pathophysiology and clinical implications. J Am Geriatr Soc. 2000;48(10):1321–9.PubMedGoogle Scholar
  115. 115.
    Weiss JP, Blaivas JG. Nocturnal polyuria versus overactive bladder in nocturia. Urology. 2002;60(5 Suppl 1):28,32. discussion 32.PubMedGoogle Scholar
  116. 116.
    Asplund R, Aberg HE. Nocturia in relation to body mass index, smoking and some other life-style factors in women. Climacteric. 2004;7(3):267–73.PubMedGoogle Scholar
  117. 117.
    Laven BA, Orsini N, Andersson SO, Johansson JE, Gerber GS, Wolk A. Birth weight, abdominal obesity and the risk of lower urinary tract symptoms in a population based study of Swedish men. J Urol. 2008;179(5):1891,5. discussion 1895-6.PubMedGoogle Scholar
  118. 118.
    Bing MH, Moller LA, Jennum P, Mortensen S, Lose G. Nocturia and associated morbidity in a Danish population of men and women aged 60-80 years. BJU Int. 2008 Sep;102(7):808–14. discussion 814-5.Google Scholar
  119. 119.
    Shiri R, Hakama M, Hakkinen J, Auvinen A, Huhtala H, Tammela TL, et al. The effects of lifestyle factors on the incidence of nocturia. J Urol. 2008;180(5):2059–62.PubMedGoogle Scholar
  120. 120.
    Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ. Effects of diabetes on female voiding behavior. J Urol. 2004;172(3):989–92.PubMedGoogle Scholar
  121. 121.
    Fitzgerald MP, Mulligan M, Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol. 2006;194(5):1399–403.PubMedGoogle Scholar
  122. 122.
    Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ, et al. Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men. Diabetes Care. 2008;31(3):476–82.PubMedGoogle Scholar
  123. 123.
    Abrams P, Artibani W, Cardozo L, Dmochowski R, van Kerrebroeck P, Sand P, et al. Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn. 2009;28(4):287.PubMedGoogle Scholar
  124. 124.
    Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol. 2006;175(3 Pt 2):S5–S10.PubMedGoogle Scholar
  125. 125.
    Krystal AD, Preud'homme XA, Amundsen CL, Webster GD. Detrusor overactivity persisting at night and preceding nocturia in patients with overactive bladder syndrome: a nocturnal cystometrogram and polysomnogram study. J Urol. 2010;184(2):623–8.PubMedGoogle Scholar
  126. 126.
    Tikkinen KA, Tammela TL, Rissanen AM, Valpas A, Huhtala H, Auvinen A. Is the prevalence of overactive bladder overestimated? A population-based study in Finland. PLoS ONE. 2007;2:e195.PubMedCentralPubMedGoogle Scholar
  127. 127.
    Michel MC, de la Rosette JJ. Role of muscarinic receptor antagonists in urgency and nocturia. BJU Int. 2005;96 Suppl 1:37–42.PubMedGoogle Scholar
  128. 128.
    Thakar R, Ayers S, Clarkson P, Stanton S, Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med. 2002;347(17):1318–25.PubMedGoogle Scholar
  129. 129.
    Vervest HA, Kiewiet de Jonge M, Vervest TM, Barents JW, Haspels AA. Micturition symptoms and urinary incontinence after non-radical hysterectomy. Acta Obstet Gynecol Scand. 1988;67(2):141–6.PubMedGoogle Scholar
  130. 130.
    Virtanen H, Makinen J, Tenho T, Kiilholma P, Pitkanen Y, Hirvonen T. Effects of abdominal hysterectomy on urinary and sexual symptoms. Br J Urol. 1993;72(6):868–72.PubMedGoogle Scholar
  131. 131.
    Altman D, Lopez A, Falconer C, Zetterstrom J. The impact of hysterectomy on lower urinary tract symptoms. Int Urogynecol J Pelvic Floor Dysfunct. 2003;14(6):418–23.PubMedGoogle Scholar
  132. 132.
    Prasad M, Sadhukhan M, Tom B, Al-Taher H. The effect of hysterectomy on urinary symptoms and residual bladder volume. J Obstet Gynaecol. 2002;22(5):544–7.PubMedGoogle Scholar
  133. 133.
    Brown CT, O'Flynn E, Van Der Meulen J, Newman S, Mundy AR, Emberton M. The fear of prostate cancer in men with lower urinary tract symptoms: should symptomatic men be screened? BJU Int. 2003;91(1):30–2.PubMedGoogle Scholar
  134. 134.
    Young JM, Muscatello DJ, Ward JE. Are men with lower urinary tract symptoms at increased risk of prostate cancer? A systematic review and critique of the available evidence. BJU Int. 2000;85(9):1037–48.PubMedGoogle Scholar
  135. 135.
    Martin RM, Vatten L, Gunnell D, Romundstad P, Nilsen TI. Lower urinary tract symptoms and risk of prostate cancer: the HUNT 2 Cohort. Norway Int J Cancer. 2008;123(8):1924–8.Google Scholar
  136. 136.
    Damber JE, Aus G. Prostate cancer. Lancet. 2008;371(9625):1710–21.PubMedGoogle Scholar
  137. 137.
    Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358(12):1250–61.PubMedGoogle Scholar
  138. 138.
    Namiki S, Saito S, Ishidoya S, Tochigi T, Ioritani N, Yoshimura K, et al. Adverse effect of radical prostatectomy on nocturia and voiding frequency symptoms. Urology. 2005;66(1):147–51.PubMedGoogle Scholar
  139. 139.
    Namiki S, Ishidoya S, Saito S, Satoh M, Tochigi T, Ioritani N, et al. Natural history of voiding function after radical retropubic prostatectomy. Urology. 2006;68(1):142–7.PubMedGoogle Scholar
  140. 140.
    Hsieh CH, Chen HY, Hsu CS, Chang ST, Chiang CD. Risk factors for nocturia in Taiwanese women aged 20-59 years. Taiwan J Obstet Gynecol. 2007;46(2):166–70.PubMedGoogle Scholar
  141. 141.
    Klein BE, Klein R, Lee KE, Bruskewitz RC. Correlates of urinary symptom scores in men. Am J Public Health. 1999;89(11):1745–8.PubMedCentralPubMedGoogle Scholar
  142. 142.
    Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, et al. Risk behaviours and benign prostatic hyperplasia. BJU Int. 2004;93(9):1241–5.PubMedGoogle Scholar
  143. 143.
    Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988;2(8623):1267–73.PubMedGoogle Scholar
  144. 144.
    Fillmore KM, Stockwell T, Chikritzhs T, Bostrom A, Kerr W. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann Epidemiol. 2007;17(5 Suppl):S16–23.PubMedGoogle Scholar
  145. 145.
    Naimi TS, Brown DW, Brewer RD, Giles WH, Mensah G, Serdula MK, et al. Cardiovascular risk factors and confounders among nondrinking and moderate-drinking U.S. adults. Am J Prev Med. 2005;28(4):369–73.PubMedGoogle Scholar
  146. 146.
    Jackson R, Broad J, Connor J, Wells S. Alcohol and ischaemic heart disease: probably no free lunch. Lancet. 2005;366(9501):1911–2.PubMedGoogle Scholar
  147. 147.
    Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med. 1998;158(21):2349–56.PubMedGoogle Scholar
  148. 148.
    Prezioso D, Catuogno C, Galassi P, D'Andrea G, Castello G, Pirritano D. Life-style in patients with LUTS suggestive of BPH. Eur Urol. 2001;40 Suppl 1:9–12.PubMedGoogle Scholar
  149. 149.
    Rohrmann S, Crespo CJ, Weber JR, Smit E, Giovannucci E, Platz EA. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int. 2005;96(1):77–82.PubMedGoogle Scholar
  150. 150.
    Soda T, Masui K, Okuno H, Terai A, Ogawa O, Yoshimura K. Efficacy of nondrug lifestyle measures for the treatment of nocturia. J Urol. 2010;184(3):1000–4.PubMedGoogle Scholar
  151. 151.
    Kupelian V, Link CL, Hall SA, McKinlay JB. Are racial/ethnic disparities in the prevalence of nocturia due to socioeconomic status? Results of the BACH Survey. J Urol. 2009;181(4):1756–63.PubMedCentralPubMedGoogle Scholar
  152. 152.
    Markland AD, Vaughan CP, Johnson TM, Goode PS, Redden DT, Burgio KL. Prevalence of nocturia in United States men: results from the National Health and Nutrition Examination Survey. J Urol. 2011;185(3):998–1002.PubMedGoogle Scholar
  153. 152.
    Gopal M, Sammel MD, Pien G, Gracia C, Freeman EW, Lin H, et al. Investigating the associations between nocturia and sleep disorders in perimenopausal women. J Urol. 2008;180(5):2063–7.PubMedCentralPubMedGoogle Scholar
  154. 153.
    Munro-Faure AD, Beilin LJ, Bulpitt CJ, Coles EC, Dollery CT, Gear JS, et al. Comparison of black and white patients attending hypertension clinics in England. Br Med J. 1979;1(6170):1044–7.PubMedCentralPubMedGoogle Scholar
  155. 154.
    Sze EH, Jones WP, Ferguson JL, Barker CD, Dolezal JM. Prevalence of urinary incontinence symptoms among black, white, and Hispanic women. Obstet Gynecol. 2002;99(4):572–5.PubMedGoogle Scholar
  156. 155.
    Lukacz ES, Whitcomb EL, Lawrence JM, Nager CW, Luber KM. Urinary frequency in community-dwelling women: what is normal? Am J Obstet Gynecol. 2009;200(5):552.e1. 552.e7.Google Scholar
  157. 156.
    Kuo HC. Prevalence of lower urinary tract symptoms in male Aborigines and non-Aborigines in eastern Taiwan. J Formos Med Assoc. 2008;107(9):728–35.PubMedGoogle Scholar
  158. 157.
    Chuang FC, Kuo HC. Prevalence of lower urinary tract symptoms in indigenous and non-indigenous women in Eastern Taiwan. J Formos Med Assoc. 2010;109(3):228–36.PubMedGoogle Scholar
  159. 158.
    Mariappan P, Turner KJ, Sothilingam S, Rajan P, Sundram M, Stewart LH. Nocturia, nocturia indices and variables from frequency-volume charts are significantly different in Asian and Caucasian men with lower urinary tract symptoms: a prospective comparison study. BJU Int. 2007;100(2):332–6.PubMedGoogle Scholar
  160. 159.
    Bing MH, Moller LA, Jennum P, Mortensen S, Lose G. Validity and reliability of a questionnaire for evaluating nocturia, nocturnal enuresis and sleep-interruptions in an elderly population. Eur Urol. 2006;49(4):710–9.PubMedGoogle Scholar
  161. 160.
    Schou J, Poulsen AL, Nordling J. The value of a new symptom score (DAN-PSS) in diagnosing uro-dynamic infravesical obstruction in BPH. Scand J Urol Nephrol. 1993;27(4):489–92.PubMedGoogle Scholar
  162. 161.
    Barry MJ, Fowler Jr FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549. 1557, discussion 1564.PubMedGoogle Scholar
  163. 162.
    Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77(6):805–12.PubMedGoogle Scholar
  164. 163.
    Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos-Ferreira A, et al. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society–Benign Prostatic Hyperplasia. Br J Urol. 1997;80(5):712–21.PubMedGoogle Scholar
  165. 164.
    Barry MJ, Fowler Jr FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Measuring disease-specific health status in men with benign prostatic hyperplasia. Measurement Committee of The American Urological Association. Med Care. 1995;33(4 Suppl):AS145–55.PubMedGoogle Scholar
  166. 165.
    The EuroQol Group. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.Google Scholar
  167. 166.
    Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4.PubMedCentralPubMedGoogle Scholar
  168. 167.
    Hays RD, Sherbourne CD. The RAND 36-Item Health Survey 1.0. Health Econ. 1993;2(3):217–27.PubMedGoogle Scholar
  169. 168.
    Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001;33(5):328–36.PubMedGoogle Scholar
  170. 169.
    Osoba D. Guidelines for measuring quality of life in clinical trials. In: Staquet MJ, Hays RD, Fayers PM, editors. Quality of Life assessment in clinical trials. Oxford: Oxford University Press; 1998.Google Scholar
  171. 170.
    McKown S, Abraham L, Coyne K, Gawlicki M, Piault E, Vats V. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTSsex questionnaires in 16 languages. Int J Clin Pract. 2010;64(12):1643–52.PubMedGoogle Scholar
  172. 171.
    Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.PubMedGoogle Scholar
  173. 172.
    van Dijk L, Kooij DG, Schellevis FG, Kaptein AA, Boon TA, Wooning M. Nocturia: impact on quality of life in a Dutch adult population. BJU Int. 2004;93(7):1001–4.PubMedGoogle Scholar
  174. 173.
    van Diest R, Appels WP. Sleep physiological characteristics of exhausted men. Psychosom Med. 1994;56(1):28–35.PubMedGoogle Scholar
  175. 174.
    Epstein RS, Deverka PA, Chute CG, Panser L, Oesterling JE, Lieber MM, et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol. 1992;45(12):1431–45.PubMedGoogle Scholar
  176. 175.
    A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. J Urol 1993;150(5 Pt 2):1696–7000Google Scholar
  177. 176.
    Girman CJ, Epstein RS, Jacobsen SJ, Guess HA, Panser LA, Oesterling JE, et al. Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology. 1994;44(6):825–31.PubMedGoogle Scholar
  178. 177.
    Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res. 1994;3(5):291–306.PubMedGoogle Scholar
  179. 178.
    Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol. 1997;104(12):1374–9.PubMedGoogle Scholar
  180. 179.
    Donovan JL. Measuring the impact of nocturia on quality of life. BJU Int. 1999;84 Suppl 1:21–5.PubMedGoogle Scholar
  181. 180.
    Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353–65.PubMedGoogle Scholar
  182. 181.
    Kobelt G, Borgstrom F, Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int. 2003;91(3):190–5.PubMedGoogle Scholar
  183. 182.
    Roberts W (1860) Observations on some of the daily changes of the urine. 5:817–825,906–923Google Scholar
  184. 183.
    Norn M (1929) Über Schwankungen der Kalium-, Natrium- und Chloridausscheidung durch die Niere im Laufe des Tages [Fluctuations of the potassium, sodium and chloride excretion by the kidney in the course of the day] 55:184–210Google Scholar
  185. 184.
    Kirkland JL, Lye M, Levy DW, Banerjee AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. Br Med J (Clin Res Ed). 1983;287(6406):1665–7.Google Scholar
  186. 185.
    Matthiesen TB, Rittig S, Norgaard JP, Pedersen EB, Djurhuus JC. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol. 1996;156(4):1292–9.PubMedGoogle Scholar
  187. 186.
    Blanker MH, Bernsen RM, Bosch JL, Thomas S, Groeneveld FP, Prins A, et al. Relation between nocturnal voiding frequency and nocturnal urine production in older men: a population-based study. Urology. 2002;60(4):612–6.PubMedGoogle Scholar
  188. 187.
    van Mastrigt R, Eijskoot F. Analysis of voided urine volumes measured using a small electronic pocket balance. Scand J Urol Nephrol. 1996;30(4):257–63.PubMedGoogle Scholar
  189. 188.
    Weiss JP, Blaivas JG, Jones M, Wang JT, Guan Z. 037 Study Group. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol. 2007;178(2):548,51.PubMedGoogle Scholar
  190. 189.
    Karet FE. Disorders of water and acid-base homeostasis. Nephron Physiol. 2011;118(1):28–34.Google Scholar
  191. 190.
    Saborio P, Tipton GA, Chan JC. Diabetes insipidus. Pediatr Rev. 2000;21(4):122. quiz 129.PubMedGoogle Scholar
  192. 191.
    Thrasher TN. Baroreceptor regulation of vasopressin and renin secretion: low-pressure versus high-pressure receptors. Front Neuroendocrinol. 1994;15(2):157–96.PubMedGoogle Scholar
  193. 192.
    Weiss JP, Bosch JL, Drake M, Dmochowski RR, Hashim H, Hijaz A, et al. Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011. Neurourol Urodyn. 2012;31(3):330–9.PubMedGoogle Scholar
  194. 193.
    Penniston KL, Tanumihardjo SA. The acute and chronic toxic effects of vitamin A. Am J Clin Nutr. 2006;83(2):191–201.PubMedGoogle Scholar
  195. 194.
    Bringhurst R, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders Elsevier; 2008.Google Scholar
  196. 195.
    Dubeau CE, Tsui JF. Nocturia in the elderly. In: Weiss JP, Blaivas JG, van Kerrebroeck PEV, Wein AJ, editors. Nocturia: causes, consequences, and clinical approaches New York. NY: Springer; 2012. p. 147–55.Google Scholar
  197. 196.
    Weiss JP, Zinner NR, Klein BM, Norgaard JP. Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. Neurourol Urodyn. 2012;31(4):441–7.PubMedGoogle Scholar
  198. 197.
    Johnson TM, Burgio KL, Redden DT, Wright KC, Goode PS. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc. 2005;53(5):846–50.PubMedGoogle Scholar
  199. 198.
    Johnson TM, Jones K, Williford WO, Kutner MH, Issa MM, Lepor H. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol. 2003;170(1):145–8.PubMedGoogle Scholar
  200. 199.
    Lose G, Lalos O, Freeman RM, van Kerrebroeck P, Nocturia Study Group. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol. 2003;189(4):1106–13.PubMedGoogle Scholar
  201. 200.
    Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int. 2002;89(9):855–62.PubMedGoogle Scholar
  202. 201.
    Smith AL, Wein AJ. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? BJU Int. 2011;107(10):1550–4.PubMedGoogle Scholar
  203. 202.
    Weiss JP, Blaivas JG, Stember DS, Brooks MM. Nocturia in adults: etiology and classification. Neurourol Urodyn. 1998;17(5):467–72.PubMedGoogle Scholar
  204. 203.
    Weatherall M, Arnold T. New Zealand Nocturia Guideline Committee. Nocturia in adults: draft New Zealand guidelines for its assessment and management in primary care. N Z Med J. 2006;119(1234):U1976.PubMedGoogle Scholar
  205. 204.
    Vaughan CP, Endeshaw Y, Nagamia Z, Ouslander JG, Johnson TM. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. BJU Int. 2009;104(1):69–74.PubMedGoogle Scholar
  206. 205.
    Fitzgerald MP, Lemack G, Wheeler T, Litman HJ. Urinary incontinence treatment network. Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(11):1545–50.PubMedCentralPubMedGoogle Scholar
  207. 206.
    Burgio KL, Goode PS, Johnson TM, Hammontree L, Ouslander JG, Markland AD, et al. Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial. J Am Geriatr Soc. 2011;59(12):2209–16.PubMedGoogle Scholar
  208. 207.
    Weiss JP, Blaivas JG, Bliwise DL, Dmochowski RR, Dubeau CE, Lowe FC, et al. The evaluation and treatment of nocturia: a consensus statement. BJU Int. 2011;108(1):6–21.PubMedGoogle Scholar
  209. 208.
    Wagg A, Wyndaele JJ, Sieber P. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Am J Geriatr Pharmacother. 2006;4(1):14–24.PubMedGoogle Scholar
  210. 209.
    Kaplan SA, Roehrborn CG, Rovner ES, Carlsson M, Bavendam T, Guan Z. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006;296(19):2319–28.PubMedGoogle Scholar
  211. 210.
    Rackley R, Weiss JP, Rovner ES, Wang JT, Guan Z. 037 STUDY GROUP. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006;67(4):731,6.PubMedGoogle Scholar
  212. 211.
    Vardy MD, Mitcheson HD, Samuels TA, Wegenke JD, Forero-Schwanhaeuser S, Marshall TS, et al. Effects of solifenacin on overactive bladder symptoms, symptom bother and other patient-reported outcomes: results from VIBRANT - a double-blind, placebo-controlled trial. Int J Clin Pract. 2009;63(12):1702–14.PubMedGoogle Scholar
  213. 212.
    Chapple C, Steers W, Norton P, Millard R, Kralidis G, Glavind K, et al. A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder. BJU Int. 2005;95(7):993–1001.PubMedGoogle Scholar
  214. 213.
    Nitti VW, Dmochowski R, Appell RA, Wang JT, Bavendam T, Guan Z, et al. Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia. BJU Int. 2006;97(6):1262–6.PubMedGoogle Scholar
  215. 214.
    Herschorn S, Stothers L, Carlson K, Egerdie B, Gajewski JB, Pommerville P, et al. Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial. J Urol. 2010;183(5):1892–8.PubMedGoogle Scholar
  216. 215.
    Yokoyama O, Yamaguchi O, Kakizaki H, Itoh N, Yokota T, Okada H, et al. Efficacy of solifenacin on nocturia in Japanese patients with overactive bladder: impact on sleep evaluated by bladder diary. J Urol. 2011;186(1):170–4.PubMedGoogle Scholar
  217. 216.
    Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, et al. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med. 2005;165(7):808–13.PubMedGoogle Scholar
  218. 217.
    Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Fernandez Fernandez E, et al. Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Eur Urol. 2011;59(3):342–52.PubMedGoogle Scholar
  219. 218.
    Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, et al. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. JAMA. 2011;306(12):1344–51.PubMedCentralPubMedGoogle Scholar
  220. 219.
    Drake MJ, Mills IW, Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol. 2004;171(3):1199–202.PubMedGoogle Scholar
  221. 220.
    Sugaya K, Nishijima S, Miyazato M, Kadekawa K, Ogawa Y. Effects of melatonin and rilmazafone on nocturia in the elderly. J Int Med Res. 2007;35(5):685–91.PubMedGoogle Scholar
  222. 221.
    Lowenstein L, Kenton K, Brubaker L, Pillar G, Undevia N, Mueller ER, et al. The relationship between obstructive sleep apnea, nocturia, and daytime overactive bladder syndrome in women. Am J Obstet Gynecol. 2008;198(5):598.e1. 598.e5.Google Scholar
  223. 222.
    Seiler WO, Stahelin HB, Hefti U. Desmopressin reduces night urine volume in geriatric patients: implication for treatment of the nocturnal incontinence. Clin Investig. 1992;70(7):619.PubMedGoogle Scholar
  224. 223.
    Asplund R, Aberg H. Desmopressin in elderly subjects with increased nocturnal diuresis. A two-month treatment study. Scand J Urol Nephrol. 1993;27(1):77–82.PubMedGoogle Scholar
  225. 224.
    Asplund R, Aberg H. Desmopressin in elderly women with increased nocturnal diuresis. A short-term study. Br J Urol. 1993;72(1):42–5.PubMedGoogle Scholar
  226. 225.
    Asplund R, Sundberg B, Bengtsson P. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. BJU Int. 1999;83(6):591–5.PubMedGoogle Scholar
  227. 226.
    Assassa RP, Osborn DE, Castleden CM. Male lower urinary tract symptoms: is surgery always necessary? Gerontology. 1998;44(2):61–6.PubMedGoogle Scholar
  228. 227.
    Cannon A, Carter PG, McConnell AA, Abrams P. Desmopressin in the treatment of nocturnal polyuria in the male. BJU Int. 1999;84(1):20–4.PubMedGoogle Scholar
  229. 228.
    Chancellor MB, Atan A, Rivas DA, Watanabe T, Tai HL, Kumon H. Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results. Tech Urol. 1999;5(4):191–4.PubMedGoogle Scholar
  230. 229.
    Kuo HC. Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years. Urology. 2002;59(4):485–9.PubMedGoogle Scholar
  231. 230.
    Rembratt A, Norgaard JP, Andersson KE. Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns. BJU Int. 2003;91(7):642–6.PubMedGoogle Scholar
  232. 231.
    Wang CJ, Lin YN, Huang SW, Chang CH. Low dose oral desmopressin for nocturnal polyuria in patients with benign prostatic hyperplasia: a double-blind, placebo controlled, randomized study. J Urol. 2011;185(1):219–23.PubMedGoogle Scholar
  233. 232.
    Rezakhaniha B, Arianpour N, Siroosbakhat S. Efficacy of desmopressin in treatment of nocturia in elderly men. J Res Med Sci. 2011;16(4):516–23.PubMedCentralPubMedGoogle Scholar
  234. 233.
    Fu FG, Lavery HJ, Wu DL. Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin. Neurourol Urodyn. 2011;30(3):312–6.PubMedGoogle Scholar
  235. 234.
    van Kerrebroeck P, Rezapour M, Cortesse A, Thuroff J, Riis A, Norgaard JP. Desmopressin in the treatment of nocturia: a double-blind, placebo-controlled study. Eur Urol. 2007;52(1):221–9.PubMedGoogle Scholar
  236. 235.
    Johnson TM, Burridge A, Issa MM, Miller M, Tang T, Ouslander JG. The relationship between the action of arginine vasopressin and responsiveness to oral desmopressin in older men: a pilot study. J Am Geriatr Soc. 2007;55(4):562–9.PubMedGoogle Scholar
  237. 236.
    Bae JH, Oh MM, Shim KS, Cheon J, Lee JG, Kim JJ, et al. The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. J Urol. 2007;178(1):200–3.PubMedGoogle Scholar
  238. 237.
    Weatherall M. The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis. Neurourol Urodyn. 2004;23(4):302–5.PubMedGoogle Scholar
  239. 238.
    Weiss JP, Wein AJ, van Kerrebroeck P, Dmochowski R, Fitzgerald M, Tikkinen KA, et al. Nocturia: new directions. Neurourol Urodyn. 2011;30(5):700–3.PubMedGoogle Scholar
  240. 239.
    Johnson TM, Miller M, Tang T, Pillion DJ, Ouslander JG. Oral ddAVP for nighttime urinary incontinence in characterized nursing home residents: a pilot study. J Am Med Dir Assoc. 2006;7(1):6–11.PubMedGoogle Scholar
  241. 240.
    Rembratt A, Graugaard-Jensen C, Senderovitz T, Norgaard JP, Djurhuus JC. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. Eur J Clin Pharmacol. 2004;60(6):397–402.PubMedGoogle Scholar
  242. 241.
    Rembratt A, Riis A, Norgaard JP. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn. 2006;25(2):105–9.PubMedGoogle Scholar
  243. 242.
    Juul KV, Klein BM, Sandstrom R, Erichsen L, Norgaard JP. Gender difference in antidiuretic response to desmopressin. Am J Physiol Renal Physiol. 2011;300(5):F1116–22.PubMedGoogle Scholar
  244. 243.
    Kok AL, Burger CW, van de Weijer PH, Voetberg GA, Peters-Muller ER, Kenemans P. Micturition complaints in postmenopausal women treated with continuously combined hormone replacement therapy: a prospective study. Maturitas. 1999;31(2):143–9.PubMedGoogle Scholar
  245. 244.
    Pedersen PA, Johansen PB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol. 1988;62(2):145–7.PubMedGoogle Scholar
  246. 245.
    (2010) Committee for establishment of the clinical guidelines for Nocturia of the Neurogenic Bladder Society. Clinical guidelines for nocturia. Int J Urol 17(5):397–409.Google Scholar
  247. 246.
    Peters KM, Carrico DJ, Perez-Marrero RA, Khan AU, Wooldridge LS, Davis GL, et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUMIT trial. J Urol. 2010;183(4):1438–43.PubMedGoogle Scholar
  248. 247.
    MacDiarmid SA, Peters KM, Shobeiri SA, Wooldridge LS, Rovner ES, Leong FC, et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010;183(1):234–40.PubMedGoogle Scholar
  249. 248.
    Hakenberg OW, Pinnock CB, Marshall VR. Does evaluation with the International Prostate Symptom Score predict the outcome of transurethral resection of the prostate? J Urol. 1997;158(1):94–9.PubMedGoogle Scholar
  250. 249.
    Meyhoff HH, Nordling J. Long term results of transurethral and transvesical prostatectomy. A randomized study. Scand J Urol Nephrol. 1986;20(1):27–33.PubMedGoogle Scholar
  251. 250.
    Seki N, Yuki K, Takei M, Yamaguchi A, Naito S. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn. 2009;28(3):197–201.PubMedGoogle Scholar
  252. 251.
    Margel D, Lifshitz D, Brown N, Lask D, Livne PM, Tal R. Predictors of nocturia quality of life before and shortly after prostatectomy. Urology. 2007;70(3):493–7.PubMedGoogle Scholar
  253. 252.
    Simaioforidis V, Papatsoris AG, Chrisofos M, Chrisafis M, Koritsiadis S, Deliveliotis C. Tamsulosin versus transurethral resection of the prostate: effect on nocturia as a result of benign prostatic hyperplasia. Int J Urol. 2011;18(3):243–8.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Kari A. O. Tikkinen
    • 1
    • 2
    Email author
  • Theodore M. JohnsonII
    • 3
  • Jeffrey P. Weiss
    • 4
  1. 1.Department of UrologyHelsinki University Central Hospital and University of HelsinkiHelsinkiFinland
  2. 2.Department of Clinical Epidemiology and BiostatisticsMcMaster UniversityHamiltonCanada
  3. 3.Emory Division of General Medicine and Geriatrics, Department of MedicineAtlanta VA Medical CenterDecaturUSA
  4. 4.Department of UrologySUNY Downstate College of MedicineBrooklynUSA

Personalised recommendations